Home / Investors & Media / Posters & Presentations / A Robust and Scalable Platform Process for GMP Manufacturing of Lentiviral Vectors // May 3, 2022 | The American Society of Gene & Cell Therapy (ASGCT) A Robust and Scalable Platform Process for GMP Manufacturing of Lentiviral Vectors